Evotec Results Presentation Deck

PAGE 13 evotec Well-balanced global customer mix further improving Selected KPIs H1 2021 Revenue by customer type YTD¹) in % (H1 2021) Mid-sized Pharma Foundation/ NFP/Academic Biotech Top 20 Pharma 1) Third-party revenues only 14% 9% 41% 36% H1 2021 100% Revenues by region YTD¹) in % (H1 2021) Rest of World USA Europe 4% 53% 43% H1 2021 100%

View entire presentation